CHRISTINA MATTES: Open Payments
NPI 1316719685 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 32 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $355 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 10 | $235 |
| Otsuka America Pharmaceutical, Inc. | 5 | $142 |
| Calliditas Therapeutics US Inc. | 4 | $113 |
| Vantive US Healthcare LLC | 3 | $90 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $60 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Travere Therapeutics, Inc. | 2 | $55 |
| Novo Nordisk Inc | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Amgen Inc. | 1 | $19 |
Products named: ACTHAR, JYNARQUE, TARPEYO, Renal - Acute, TERLIVAZ, JARDIANCE, FARXIGA, Ozempic.
Industry payments across FL — which companies pay providers there.
